Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Axcan receives IND approval for URSO in hypercholesterolemia

April 28, 1997

Glaxo Wellcome discovers potent BAT inhibitor

April 28, 1997

Exactech and the University of Florida Tissue Bank to codevelop biologic bone repair material

April 28, 1997

Potent, selective beta3-agonist from Merck & Co.

April 25, 1997

Amino-ketones from Roche found to lower cholesterol levels in animals

April 25, 1997

NovaDx discovers osteoporosis drug opportunities

April 25, 1997

Potent, orally active ACAT inhibitors from Sankyo

April 24, 1997

Azko Nobel discloses antiglucocorticoids

April 24, 1997

Antioxidants/hypolipidemics from ADIR

April 24, 1997

Ono discloses ICE inhibitors

April 23, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...